Circulating sclerostin and dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): Relationship with bone density and arterial stiffness

Calcified Tissue International

Volumn 90, Issue 6, 2012, Pages 473-480

  Thambiah, S ^a,b,c   Roplekar, R ^a   Manghat, P ^a,b   Fogelman, I ^b   Fraser, W D ^d   Goldsmith, D ^b   Hampson, Geeta ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Arterial stiffness; Bone mineral density; Chronic kidney disease; DKK1; Sclerostin; Wnt pathway

Indexed keywords

CALCITRIOL; DICKKOPF 1 PROTEIN; PARATHYROID HORMONE; SCLEROSTIN;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BONE DENSITY; CHRONIC KIDNEY DISEASE; FEMALE; FEMUR NECK; GLOMERULUS FILTRATION RATE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE;

BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; DIALYSIS; FEMALE; GENETIC MARKERS; GLOMERULAR FILTRATION RATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VASCULAR CALCIFICATION; VASCULAR STIFFNESS; WNT SIGNALING PATHWAY;

EID: 84864280719     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9595-4     Document Type: Article

References (34)

1. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naver-Diaz M, Diaz-Lopez B (2006) Vascular calcifications: pathogenesis, management and impact on clinical outcomes. J Am Soc Nephrol 17:S267-S273 (Pubitemid 44865260)
2. London GM, Marchais SJ, Guerin AP, Metivier F (2002) Impairment of arterial function in chronic kidney disease: prognostic impact and therapeutic approach. Nephrol Dial Transplant 17(Suppl 11):13-15 (Pubitemid 35277056)
3. Shao JS, Cheng SL, Sadhu J, Towler DA (2010) Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55:579-592
4. Sage AP, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528-536
5. Shao JS, Cai J, Towler DA (2006) Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26:1423-1430 (Pubitemid 44288965)
6. Towler DA, Shao JS, Cheng SL, Pingsterhaus JM, Loewy A (2006) Osteogenic regulation of vascular calcification. Ann NY Acad Sci 1068:327-333 (Pubitemid 43824164)
7. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115:1210-1220 (Pubitemid 40629039)
8. Román-García P, Carrillo-López N, Fernández-Martín JL, Naves- Díaz M, Ruiz-Torres MP, Cannata-Andía JB (2010) High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46(1):121-128
9. Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009) Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 29(8):1228-1234
10. Zhu D, Mackenzie NC, Millán JL, Farquharson C, MacRae VE (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 6(5):e19595
11. Baron R, Rawadi G (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148(6):2635-2643 (Pubitemid 46984775)
12. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling- Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267-6276 (Pubitemid 37522584)
13. Mödder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, Melton LJ III, Khosla S (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373-379
14. Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women - The six-month effect of risedronate and teriparatide. Osteoporos Int 23(3):1171-1176
15. Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95(5):2248-2253
16. Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH (2011) Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6(4):877-882
17. Butler JS, Murray DW, Hurson CJ, O'Brien J, Doran PP, O'Byrne JM (2011) The role of Dkk1 in bone mass regulation: correlating serum Dkk1 expression with bone mineral density. J Orthop Res 29(3):414-418
18. Kaiser M, Mieth M, Liebisch P, Oberländer R, Rademacher J, Jakob C, Kleeberg L, Fleissner C, Braendle E, Peters M, Stover D, Sezer O, Heider U (2008) Serum concentrations of DKK1 correlate with the extent of bone disease in patients with multiple myeloma. Eur J Haematol 80(6):490-494 (Pubitemid 351677464)
19. Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A (2008) Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 28(5A):2613-2623
20. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):156-163
21. Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, Slane P, Whitworth C, Williams B (2007) UK Consensus Conference on early chronic kidney disease-6 and 7 February 2007. Nephrol Dial Transplant 22(9):2455-2457 (Pubitemid 47365506)
22. Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP (2008) Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. J Bone Miner Res 23(5):721-729 (Pubitemid 351575026)
23. Patel R, Blake GM, Rymer J, Fogelman I (2000) Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11(1):68-75 (Pubitemid 30099513)
24. Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Goldsmith D, Hampson G (2011) Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). Bone 48(5):1127-1132
25. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ (2002) Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond) 103(4):371-377 (Pubitemid 35193240)
26. Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U (2006) Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 48(3):456-463 (Pubitemid 44247250)
27. Gunarathne A, Patel JV, Hughes EA, Lip GY (2008) Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. Am J Hypertens 21(8):866-872
28. Cejka D, Jäger-Lansky A, Kieweg H, Weber M, Bieglmayer C, Haider DG, Diarra D, Patsch J, Kainberger F, Bohle B, Haas M (2012) Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 27(1):226-230
29. Kearns AE, Khosla S, Kosteniuk PJ (2008) Receptor activator of nuclear factor-jB ligand and osteoprotegerin regulation of bone remodelling in health and disease. Endocr Rev 29:155-192 (Pubitemid 351519689)
30. Aguilera O, Peña C, García JM, Larriba MJ, Ordóñez-Morán P, Navarro D, Barbáchano A, López de Silanes I, Ballestar E, Fraga MF, Esteller M, Gamallo C, Bonilla F, González-Sancho JM, Muñoz A (2007) The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28(9):1877-1884 (Pubitemid 47500598)
31. Cianferotti L, Demay MB (2007) VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101(1):80-88 (Pubitemid 46652574)
32. Drake MT, Srinivasan B, Mödder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95(11):5056-5062
33. van Lierop AH, Witteveen JE, Hamdy NA, Papapoulos SE (2010) Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. Eur J Endocrinol 163(5):833-837
34. Ardawi MS, Al-Sibiany AM, Bakhsh TM, Rouzi AA, Qari MH (2011) Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Osteoporos Int